Acute Lymphocytic Leukemia (ALL)
Oncology·MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| KT-253 | Kymera Therapeutics, Inc. (KYMR) |
Frequently asked questions
How many drugs are in development for Acute Lymphocytic Leukemia (ALL)?
BioSniper tracks 1 drug in development for Acute Lymphocytic Leukemia (ALL) across 1 company.
How many clinical trials target Acute Lymphocytic Leukemia (ALL)?
There are 1 clinical trial targeting Acute Lymphocytic Leukemia (ALL) tracked by BioSniper.
Deep-dive into Acute Lymphocytic Leukemia (ALL)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis